Mersana Therapeutics Inc.
(MRSN)
undefined
undefined%
At close: undefined
2.15
0.23%
After-hours Dec 13, 2024, 05:51 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Cash & Equivalents | 174.56M | 280.71M | 177.95M | 255.09M | 62.35M | 59.63M | 26.59M | 100.30M | 11.53M |
| Short-Term Investments | 34.52M | 151.83M | - | - | 37.44M | 10.50M | 88.14M | - | - |
| Long-Term Investments | - | 478.00K | 478.00K | 321.00 | 321.00K | 371.00K | 10.48M | 321.00K | - |
| Other Long-Term Assets | 478.00K | 183.00K | 1.88M | 2.15M | 1.13M | 5.31M | 371.00K | 110.00K | 371.00K |
| Receivables | - | 30.00M | - | - | - | 459.00K | 784.00K | 1.05M | 640.00K |
| Inventory | - | - | - | - | - | -4.17M | 1.00 | - | 1.00 |
| Other Current Assets | 4.97M | 8.51M | 21.90M | 3.49M | 3.07M | 7.43M | 4.05M | 825.00K | 580.00K |
| Total Current Assets | 214.06M | 319.22M | 188.90M | 258.58M | 101.33M | 70.13M | 117.54M | 102.17M | 12.75M |
| Property-Plant & Equipment | 11.53M | 14.46M | 14.86M | 12.67M | 4.76M | 2.69M | 2.32M | 2.48M | 1.28M |
| Goodwill & Intangibles | - | - | - | - | - | - | - | - | - |
| Total Long-Term Assets | 12.00M | 15.12M | 17.21M | 14.82M | 6.21M | 8.37M | 13.17M | 2.91M | 1.66M |
| Total Assets | 226.06M | 334.34M | 206.11M | 273.40M | 107.54M | 78.50M | 130.72M | 105.09M | 14.41M |
| Account Payables | 7.32M | 13.95M | 12.32M | 8.34M | 7.30M | 10.73M | 3.07M | 2.07M | 2.02M |
| Deferred Revenue | 28.15M | 30.61M | 3.94M | 3.99M | 4.82M | 46.20M | 21.64M | 22.73M | 7.05M |
| Short-Term Debt | 5.48M | 3.04M | 2.54M | 1.53M | 2.89M | - | - | - | - |
| Other Current Liabilities | 22.69M | 44.17M | 28.95M | 16.24M | 9.07M | 12.50M | 7.18M | 3.59M | 1.66M |
| Total Current Liabilities | 63.64M | 91.53M | 47.52M | 30.00M | 24.07M | 69.42M | 31.88M | 28.39M | 10.73M |
| Long-Term Debt | 28.35M | 33.50M | 35.87M | 15.13M | 4.88M | - | - | - | - |
| Other Long-Term Liabilities | 1K | 203.00K | 974.00K | 174.00K | 275.00K | 282.00K | 67.00K | 94.75M | 36.30M |
| Total Long-Term Liabilities | 125.52M | 150.75M | 36.85M | 15.31M | 5.15M | 282.00K | 28.84M | 132.32M | 46.37M |
| Total Liabilities | 189.16M | 242.28M | 84.37M | 45.31M | 29.22M | 69.71M | 60.72M | 160.71M | 57.10M |
| Total Debt | 33.83M | 36.30M | 38.18M | 16.57M | 7.76M | - | - | - | - |
| Common Stock | 12.00K | 11.00K | 7.00K | 7.00K | 5.00K | 3.00K | 3.00K | 1K | 1K |
| Retained Earnings | -826.36M | -654.69M | -450.48M | -280.42M | -192.37M | -164.17M | -97.88M | -59.17M | -45.47M |
| Comprehensive Income | 11.00K | -152.00K | - | -0.00 | 25.00K | -8.00K | -149.00K | -4.21M | -3.56M |
| Shareholders Equity | 36.90M | 92.06M | 121.74M | 228.09M | 78.32M | 8.79M | 69.99M | -55.62M | -42.69M |
| Total Investments | 34.52M | 151.83M | 478.00K | 321.00 | 37.44M | 10.50M | 98.63M | 321.00K | - |